RA Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,038,000	Closed	-$5.97M	–	90
2024 Q4	$5.97M	Buy	+1,038,000	New	+$9.95M	0.08%	82
2022 Q4	–	Sell	-896,724	Closed	-$46.5M	–	74
2022 Q3	$46.5M	Hold	896,724	–	–	0.99%	33
2022 Q2	$42.4M	Sell	896,724 -67,488	-7%	-$3.66M	1.13%	30
2022 Q1	$68.6M	Buy	+964,212	New	+$62.7M	1.5%	18
2014 Q4	–	Sell	-250,000	Closed	-$9.89M	–	54
2014 Q3	$9.89M	Sell	250,000 -1,289,586	-84%	-$51.4M	1.59%	22
2014 Q2	$66.3M	Sell	1,539,586 -1,492	-0.1%	-$56.9K	8.77%	5
2014 Q1	$61.6M	Buy	+1,541,078	New	+$56M	6.33%	10
2013 Q3	–	Sell	-436,145	Closed	-$7.72M	–	40
2013 Q2	$7.72M	Buy	+436,145	New	+$8.5M	1.25%	20